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Summary. The cytotoxic activity of peripheral-blood (PBL), lymph-node (LNC)
and tumour-infiltrating lymphocytes (TIL) from 47 patients undergoing surgery for
colon carcinoma (Duke's Stage A, 1 patient; B, 24; C, 15 and C with 'metastases, 7)
was examined in short-term 51Cr-release assays, against fresh autologous tumour
cells, allogeneic colon cancer cells and the erythroleukaemia cell line, K562. Cyto-
toxicity against autologous cells was detected in at least one effector population in
23/47 patients (49%O), with overall frequencies which did not differ for patients in
different Duke's stages of disease. By contrast, lysis of allogeneic tumour cells was
infrequent (110%) regardless of the effector population to which they were exposed.
Cytotoxicity against K562, cells highly sensitive to NK activity, though variable, was
detected in 93%O of PBL of normal donors and 83% of patients, and among the latter
showed no evidence of significant decline with advancing disease. However, LNC and
TIL anti-K562 activity was infrequent (17%) in concordance with previous reports.
There was no correlation between the ability of patients' PBL to lyse autologous
tumour and K562 cells. The independence of these 2 cytotoxic actions was further
explored in studies fractionating lymphocytes: autologous tumour killing was
augmented in T-enriched PBL; whereas the greatest anti-K562 activity was found
in the corresponding non-T fraction. Lymphocyte cytotoxicity in colonic neoplasia
is thus manifest in 2 apparently independent lymphocyte populations; a relatively
specific killer T-cell population, detectable in PBL, LNC and TIL, which is prefer-
entially reactive with the autologous cells; and a non-specific killer population,
largely limited to PBL, with the properties of NK cells. The activity of neither
population reflects the clinical status of patients with this disease.
In vitro destruction of human tumour
cells by effector cells, detectable in short-
term cytotoxicity assays, represents a
balance of the cytolytic potential of
various effector cells, their subsets and
antibodies with the affinity of target-
recognition sites and other factors con-
tributing to innate target-cell sensitivity.
Several distinct types oflymphoideffector:
tumour cell interactions are now well
recognized; antibody-dependent cellular
cytotoxicity (ADCC), T-mediated lysis
and natural killing (NK) (Perlmann &
Cerrotini, 1979). Of these, antibody-
independent lysis by cytotoxic T cells and
NK cells have been implicated in the
immunosurveillance of tumours.
The relative contribution of these
effector functions to human tumour des-
truction has not always been clear. Early
studies with cultured human targets in
long-term cytotoxicity assays claimed that
tumour-cell lysis was mediated by sensi-
tized lymphocytes in the lymphoid organs
only of donors bearing neoplasms of simi-
lar histogenic derivation to the target cells
(Baldwin et al., 1973; Hellstrom et al.,
1970; 1971; Leibold & Peter, 1978). More
recent experiments have disputed these
findings, largely on the grounds that the
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cytotoxicity of cancer-patients' lympho-
cytes for cultured tumour-derived targets
could not be distinguished from those of
normal allogeneic individuals (Takasugi
et al., 1973). In this situation, cytotoxicity
in both patients and controls is mediated
by NK cells, to which most culture-
adapted targets are susceptible. In this
respect, cultured cells differ markedly
from their in vivo counterparts which,
when tested as freshly disaggregated
single-cell suspensions, display minimal
sensitivity to natural killing (Vose &
Moore, 1980).
The respective roles of cytotoxic T cells
andNK cellsinhuman tumour destruction
in vitro is beginning to emerge, to the
extent that assays may now be designed
to discriminate in favour of each effector
function. T-mediated activity is character-
ized by exquisite specificity, classical
immunologic memory, restriction by anti-
gens of the major histocompatibility
complex, and is readily detectable against
autologous fresh human tumour cells, at
least in some cancers (Perlmann & Cerot-
tini, 1979). By contrast, NK activity is
unrelated to the previous immunization
history of the donor, displays no restric-
tion, and is manifest against a wide range
of cell lines, irrespective of histogenic
derivation (Herberman & Holden, 1978).
Important distinctions between these
effector functions are also evident from
comparison of different lymphoid organs
and tumour-infiltrating lymphocytes
(TIL). T-cell and NK functions coexist in
peripheral blood, but the latter is virtually
absent from lymph nodes, and the expres-
sion of both is depressed in lymphocytes
recovered from the tumour mass (Vose &
Moore, 1979; Vose et al., 1977).
In the present study, the cytotoxicity
of lymphocytes from patients with colon
carcinomahasbeenevaluated using freshly
isolated autologous tumour targets in
short-term 5lCr-release assays, in an
attempt to dissociate specific disease-
related cellular cytotoxicity from co-
existent natural killing. The possibility
that concentration of specifically sensi-
tized cells to the antigenic site might ren-
der PBL non-reactive (Emeson, 1978) was
also considered, by simultaneous analysis,
where possible, of lymphoid effector func-
tion in mesenteric LNC and TIL. The
observationsreportedhereextendprevious
experience of a cytotoxic reactivity in
blood, lymph node and tumour which is
demonstrably different from the NK cells
more frequently encountered in earlier
studies of colonic neoplasia, in terms of
effector-cell properties, organ distribution
and specificity.
PATIENTS AND METHODS
Patients.-Material was collected from
patients presenting with resectable colon
carcinoma. Forty ml ofvenous blood was col-
lected in heparinized tubes immediately
before anaesthetic premedication. After re-
section, a full-thickness segment of tumour
was removed together with several draining
lymph nodes in the colonic mesentery. The
nodes were separated into 2 groups: those
close (1-2 cm) to the tumour, and those at
the base of the mesentery and at least 6 cm
from the tumour. All specimens were ex-
amined histologically and staged according to
Duke's classification. PBL were also prepared
from samples from 12 known healthy labora-
tory personnel (age 23-37) and 6 lung-cancer
patients.
Tumour dispersion.-The tumour specimen
was freed of surrounding fatty tissue, finely
chopped with scalpels and washed x 3 in
Hanks' BSS to remove cell debris and mucin.
Tumour dispersion was achieved by con-
tinual stirring for 3 h at room temperature in
an enzyme mixture containing collagenase
(0 1% u/ml), hyaluronidase (0.01% u/ml) and
DNAase (0-1% Kunitz u/ml). Previous
studies have established that this mixture
gives optimal dispersion of tumour material
after short incubation (Vose, 1981) with
minimal loss ofviability.
Isolation procedures.-Cell suspensions
were freed of remaining dead cells, red cells
and polymorphs by centrifugation (1400 ,
15 min at 4°C) on gradients of lymphocyte-
separation medium (Flow Laboratories,
Irvine, Scotland). Cells collecting at the inter-
face were washed twice in RPMI, resuspended
in RPMI 1640 and 10% newborn calf serum
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(NCS) or autologous plasma, and incubated
overnight in Corning 75cm2 plastic culture
flasks to remove adherent monocyte/macro-
phages. Non-adherent cells were carefully
removed and layered (1 3 x 107 cells in 6 ml
RPMI) on to a discontinuous gradient of6 ml
Lymphocyte Separation Medium (density
1.077) overlaid with 6 ml of a 3:4 dilution of
this in PBS (density 1.055). After centrifuga-
tion (1400 g, 15 min at 400) 2 interfaces
were apparent; an upper interface consisting
primarily of tumour cells and a lower
interface containing lymphocytes, with
minimal contamination by tumour cells.
The upper interface was taken, washed in
RPMI 1640 and layered (2 x 107 cells in 2 ml
RPMI 1640) on to 4 mlNCS. Afterincubation
at room temperature for 2 h, tumour-cell
populations were removed in the lower 3 ml
ofthe gradient.
Tumour-infiltrating lymphocytes (TIL).
Cells at the lower interface were washed once
in RPMI and resuspended in 1 ml TCM. This
suspension was run into columns of nylon
fibre (0.6 g scrubbed nylon-Fenwal Labora-
tories, Illinois-in 5ml syringes with a 19G
needle attached). Columns were incubated at
37°C for 30 min, and non-adherent cells
eluted with 10 ml TCM at a flow rate of 1 ml/
min. Tumour cells remained attached to the
column, with T-enriched TIL populations in
the eluted suspension. Simultaneous analysis
of TIL composition and cytotoxic function
was rarely possible; TIL comprised 65-80%
cells rosetting with SRBC.
Blood lymphocytes.-Blood was layered on
to Lymphocyte Separation Medium and
centrifuged (1400 g 15 min at 4°C). Cells
collecting at the interface were then washed
x 3 in HBSS and resuspended in TCM or
autologous plasma. Adherent monocytes were
depleted by overnight incubation in Corning
75cm2 plastic culture flasks at 37°C in an
atmosphere of5% CO2 in air.
Lymph-node cells (LNC).-Lymph-node
tissue was minced with scissors on a 200-mesh
stainless-steel grid and pressed through the
grid into RPMI 1640. Cell suspensions were
washed twice, and lymphocytes were separ-
ated as for blood. The compositions of both
populations were similar, with 57-68% cells
rosetting with SRBC. Populations were
enriched for T cells by passage through nylon
columns (Julius et al., 1973) and separation
of cells rosetting with SRBC on density
gradients.
Cell line.-The K562 cell line, originally
derived by Lozzio & Lozzio (1973) from a
patient with chronic granulocytic leukaemia
and recently shown to have erythroleukaemic
characteristics (Andersson et al., 1979), was
maintained in suspension culture in TCM.
This cell line was used to monitor levels of
NK activity in lymphocyte effector popula-
tions, because of its extreme sensitivity to
lysis by this mechanism.
Cytotoxic assays.-Target cells (106 in 0 5
ml TCM) were labelled by the dropwise addi-
tion of 100 ,Ci sodium 51Cr-chromate (Radio-
chemical Centre, Amersham). Cells were
incubated for 1-2 h at 37°C, washed twice in
RPMI and incubated for a further hour in
TCM to reduce spontaneous 51Cr release
before further washing. Targets (0-1 ml of
5 x 104/ml in TCM) were dispersed into
Luckham LP3 tubes together with effectors
in 0 1 ml TCM to give effector:target ratios
between 50:1 and 10:1. Fluid volume was
adjusted to 0 4 ml. Tubes were centrifuged
(80 g 5 min) and incubated at 37°C for 4h
before the removal of0-2 ml ofthe supernate.
The radioactivity in these samples and in the
remaining pellets and supernates was meas-
ured in a gamma counter. Spontaneous re-
lease of5'Cr was measured in tubes containing
target cells lysed with the detergent Triton
X100 (Sigma Chemical Co.). Percentage 51Cr
release was calculated for each tube from the
formula:
% 5 Cr release=
2 x supernate sample count
supernate sample-pellet count x 100
Cytotoxicity was derived as
% cytotoxicity=
5 Cr release -
spontaneous 51Cr release
maximum 5 Cr release -
spontaneous 51Cr release
Cytotoxicity was considered positive when
mean percentage 51Cr release exceeded spon-
taneous release by at least 3 x s.d. Signifi-
cance was assessed by Mann-Whitney U test
on replicate samples.
RESULTS
Reactivity against autologous cells
Lymphocytes from 47 patients were
tested for cytotoxicity against autologous
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TABLE I.-Cytotoxicity oflymphocytesfrom
different sitesagainstautologous tumour
Cytotoxicity in effectors from
Patient Near Far
no. PBL node node TIL
Duke's Stage B (12/24 show cytotoxicity against
autologous tumour in at least one population)
7
11
13
15
17
24
25
26
36
40
49
54
11-4*
19.9*
10-2*
19-4*
10-3*
0
0
17-6*
14-9*
12-2*
19.5*
12-3*
0
14-5*
2 0
0
12-0*
17-0*
37-1*
6 -5
8-7
21 -1*
13-2*
18-3*
4 0
0
0
6-2
19-2*
0
20.0*
8-5
0
Duke's Stage C (8/15 show cytotoxicity)
1 0 20-0* 0
9 13-7* 8-0* 16-7*
19 19-3* 11-3* 16-0* -
22 50.4* 31-6* 15-2* 5-9
31 19-9* 19-7* 14-3* 11.9*
38 9.1* 1-9 10-9*
50 24-1* 41-4* 72-6*
57 15-2* 15-9* 5-4 10-4*
Duke's Stage C+Metastases (3/7 show cytotoxicity)
2 8-5* 0 8-4*
12 11-1* 13-1*
60 21-0* 14-8* 14-4* 17-5*
*P<0.05.
colon-tumour cells. Duke's staging ofthese
patients showed one Stage A, 24 Stage
B, 15 Stage C and 7 Stage C with distant
metastases. Overall, 23/47 patients showed
significant lytic activity in at least one
lymphocyte preparation. The frequencies
of positive reactions for PBL, near nodes,
far nodes and TIL were 20/44, 14/43,
10/36 and 5/14 respectively. Data from
these positive cases are presented in
Table I and summarized in Table II.
Positive cytotoxic reactions ranged from
8 to 72.6%. In most cases, several effector
populations from individual patients
showed reactivity against autologous cells.
In 5 patients (7, 13, 15, 26, 54) lytic
potential was limited to blood, and in 3
(24, 25, 1) to node. All others (15 cases)
had cytotoxicity in 2-4 effector samples.
Several cases showed widespread lytic
activity through the different lymphocyte
TABLE IJ.-Cytotoxicity of lymphocytes
from different sites against autologous
colon-tumour cells
Frequency of reactive effectors from:
(Percentages in parentheses)
I. I
Duke's
stage PBL
A 0/1
B 10/22 (45)
C 7/14 (50)
C + Mets 3/7 (43)
Total 20/44 (45)
Near Far
node node
0/1
6/23 (26)
6/12 (50)
2/7 (29)
14/43 (33)
TIL
0/1
3/17 (18) 0/5 (0)
5/13 (38) 4/6 (67)
2/5 (40) 1/3 (33)
10/36 (28) 5/14 (36)
populations. This is particularly notice-
able in Stage C. Cytotoxicity, when detect-
able, was dose dependent over the range
tested (10:1-50:1). Only the higher ratio
ispresented inTable I.
In comparing the number of positive
cases in different stages of disease, there
was little evidence of association of reac-
tivity with disease stage, though the low
number of cases makes useful comparison
difficult. Similarly, nosignificant difference
in frequency ofreactivity in different sites
was apparent, except in TIL in Stage B,
where no positives were recorded. Reactive
TIL samples occurred in Stage C (4/6 posi-
tive) and C with distant metastases (1/3
positive).
Preliminary attempts to characterize
the cytotoxic effectors were made by
enrichment of T lymphocytes by passage
through nylon columns (Julius et al.,
1973) or separation of cells forming
rosettes with sheep red blood cells (SRBC)
(Jondall et al., 1972). Both methods
enrichedT cellsfrom 60% inunseparated
samples to > 85%. In almost all cases
greater cytotoxicity for autologous colon-
tumour cells was found in T-enriched
populations (Fig. 1) and in 7 cases sig-
nificant reactivity was induced in T-
enriched preparations from previously
unreactive samples. In view of these data,
samples wereseparatedbypassagethrough
nylon columns and SRBC rosetting when-
ever sufficient material was available, and
it is the enhanced values for cytotoxicity
in T-enriched populations that are shown
in Table I. Enrichment ofeffector function
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T Cell Enriched T Cell Depleted
Nylon Column Nylon Column
Passed Attached
b
T Cell Enriched
SRBC Rosetting
T Cell Depleted
SRBC Non-Rosetting
FIG. 1. Enrichment of cytotoxic activity of PBL for autologous colon-tumour cells by (a) passage
tlhrough nylon columns or (b) separation of SRBC rosette-forming cells. Effector: target ratio 40: 1.
was apparent in both PBL (Fig. 1) and
LNC (data not shown).
Cytotoxicity again8t allogeneic tumour
Specificity studies were performed by:
(1) Testing the lymphocytes from colon-
cancer patients against allogeneic colon-
tumour cells; or (2) Testing lymphocytes
from healthy donors against colon cancer
(Table III). Blood lymphocytes from 12
healthy donors and 6 lung-tumour patients
were tested, and 4 positive reactions
against allogeneic colon cells recorded
(3 with healthy donors). In all 4 of the
cases effectors autologous with the target
cells were also positive. The exact nature
ofthe cytolytic interaction in these 4 cases
has not been fully characterized. Lympho-
TABLE III. Specific and non-specific cyto-
toxicity in colon carcinoma
Frequency of significant
cytotoxicity against
(Pereentages in parentheses)
Effectors
PBL
Near node
Far node
TIL
Control PBL
Autologous
colon-
tumour cells
20/44 (45)
14/43 (33)
10/36 (28)
5/14 (36)
Allogeneit
colon-
tumour cells K562
2/18 (11) 31/36 (86)
1/14 (7) 6/37 (16)
0/11 (0) 4/32 (13)
0/1 2/12 (17)
4/18 (22) 14/15 (93)
cytes from autologous LN were also cyto-
toxic, but did not kill K562. Levels of
such "inappropriate" kill by the 4 reactive
control donors (12.7-2244%) approached
those found in autologous combinations.
Two of the 4 positive controls killed a
range oftargets including colon-carcinoma
and lung-carcinoma cells, and cytotoxicity
was again concentrated in nylon-column-
20-
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FIG. 2. Blocking of cytotoxicity of PBL for
autologous tumour by admixture of un-
labelled cells. Effectors and targets (E: T
20:1) were mixed in Luckham LP3 tubes
and increasing numbers of unlabelled
autologous (0) or allogeneic ( 0) colon-
tumour cells added prior to centrifugation.
* Significant reduction of cytotoxicity.
c
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passed SRBC-rosetting cells. When colon-
cancer patient's lymphocytes were tested
against allogeneic targets, two positive
reactions were found in blood and one
reaction in nodes, in a total of 18 cross
tests. The target cells in these cases were
susceptible to autologous killing. The
number of TIL was limited so that it was
possible to test only one of these against
control cells. As an additional specificity
control, the capacity of unlabelled tumour
cells to interfere with killing of autologous
tumour or K562 was tested. Blocking of
cytotoxicity against autologous tumour
was foundonly with theautologous tumour
(Fig. 2). Allogeneic cells were inactive in
these cold inhibition assays. Similarly
colon-carcinoma cells did not block lysis
ofK562 by lymphocytes from colon-cancer
patients or healthy controls under condi-
tions where unlabelled K562 gave sig-
nificant dose-dependent inhibition of lysis.
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Effector Lymphocytes
*4±4
Til
FIG. 4.-Cytotoxicity of lymphocytes from
(ifferent sites from patients with Duke's
Stage B colon carcinoma against K562
cells. Mean reactivity±s.d. is presentedl.
Effector: target ratio 40: 1.
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'0 62 colon-cancer patients (Table III) (31/36,
,ions were tested for 86%, reactive) though the levels of killing
the K562 cell line, were extremely variable (2-65% in con-
e the levels of NK trols and 0-64% in patients). Comparison
f K562 targets was of the cytotoxic potential of lymphocytes
samples from both from patients with different stages of
93%0, reactive) and disease and controls revealed no deficit of
activity in any group (Fig. 3). In healthy
donor and disease groups the mean reac-
tivity and range of results was closely
similar, and no significant differences were
: * * found. By contrast, lymphocytes from
* * draining nodes were only rarely cytotoxic
for the cell line, as were those isolated
28 3325 from the tumour mass. All data for Stage
24±17 B cases are presented in Fig. 4, where
identical patterns of reactivity are seen in
Stage C and C+metastases. In the total
series of 69 nodes from 38 patients, 10
significantly reactive samples were recor-
T~ ,+ ded, but levels of cytotoxicity, even in
Metastases positive nodes, were less than those
Stage achieved with PBL from the same indi-
PBL from healthy vidual. The reactivity of nodes was not
Ltients of different related to disease stage (JA, 5B, 3C and
2 cell line. Numbers IC with metastases) distance from tumour
nean+s.dl. No signi- (6 near, 4 far) or node histology (2 sinus
ngroups was found far) hisorlog I
et ratio 40:1 histocytosis, 4 tumour, 4 normal). In all
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Fia. 5.-Correlation of cytotoxicity at an
effector:target ratio of 40:1 against auto-
logous tumour and the K562 cell line. r=
0-10; P>0-1.
cases only one node was reactive; other
nodes from the same patient failed to
significantly damage K562. Nodes positive
against K562 showed no greater reactivity
against autologous tumour than negative
groups. Subpopulation analysis was per-
formed on 7 of these positive LNC. In all
5 tested, greatest cytotoxic potential
resided inthe SRBC-rosetting preparation.
Two further samples separated on nylon
columns showed enrichment for cytotoxi-
city in the adherent cells. TIL were cyto-
toxic in 2/12 cases (both Stage C), which
were not related to levels of cytotoxicity
in blood or lymph node.
Since effectors from blood were fre-
quently reactive against both autologous
tumour and K562, comparison was made
to determine whether levels ofkilling were
related (Fig. 5). Data were available for
36 PBL samples, but no significant corre-
lation between killing of the two para-
meters was found (correlation coefficient =
0.10, P>0-1). PBL from the 4 healthy
donors showing reactivity against colon-
carcinoma cells did not have unusually
high levels ofNK activity as measured by
lysis of K562. Additional evidence for the
independence of the two cytotoxic pheno-
mena was available from effector-cell
separation studies similar to those des-
cribed above. Passage of cells through
nylon columns had little effect on cyto-
toxicity in patients showing significant
augmentation ofcytotoxicityagainstauto-
logous cells. In a further series, highest
killing of K562 was in populations from
PBL which did not rosette with SRBC.
DISCUSSION
In this paper we have delineated two
major lymphocyte effector populations
with activity against colonic-tumour cells:
a relatively specific killer population,
detectable in blood, lymph node and
within thetumouritself, whichis preferen-
tially reactive with autologous cells; and
a non-specific killer (NK) population,
largely limited to blood, displaying high
reactivity against the K562 cell line. The
two effector types appear to be concen-
trated in lymphocyte populations with
different cell-surface-marker characteris-
tics, and to mediate mutually independent
lytic interactions with appropriate sensi-
tive targets.
The pursuit of specific disease-related
cytotoxicity against colon carcinoma has
received considerable attention, since first
reports of selective killing of allogeneic
colon-carcinoma cell lines by lymphocytes
from colon-carcinoma patients (Baldwin
et at., 1973; Hellstrom et al., 1970, 1971;
Nairn et al., 1971). With increasing
awareness of the pervasive nature of
spontaneously cytotoxic NK cells, par-
ticularly in long-term microcytotoxicity
assays, the validity of early claims has
been questioned (Takasugi et at., 1973).
Our own studies in this neoplasm are
representative of those of many labora-
tories, where extensive testing against
short-term cultures, using a variety of
normal and pathological controls, failed
to identify patterns of cytotoxicity which
were unique to the colon-cancer group
(Vose et at., 1975). In comparing the
present study with earlier investigations,
several potentially important differences
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are apparent, not least of which is the
nature of the target cells. Those used here
were derived by the sequential application
of separative techniques, exploiting dif-
ferences in size, density and adherence
properties oftumour components. By these
means, cell selection, which is invariably
associated with adaptation to tissue cul-
ture, and the concomitant induction of
sensitivity to NK-mediated lysis (Becker
et al., 1978) were obviated. Extensive
testing of similar freshly derived tumour-
cell suspensions has shown that they are
largely refractory to NK-mediated lysis
and minimally express the relevant recog-
nitive structure (Vose & Moore, 1980).
As such they share with the short-term
cultures of Nairn and associates (Nairn
et al., 1971; Pihl et al., 1976) the property
of permitting the measurement of specific
effector function (Werkmeister et al.,
1979). In addition, killing was largely
confined to autologous combinations in
short-term assays. The preference shown
for autologous cells under such conditions,
together with the characteristics of the
effector cells as well as the concentration
of effectors (i.e. enrichment of cytotoxic
efficacy by formation of SRBC rosettes
and passage through nylon columns),
support the interpretation that the pri-
marv mediators are T cells. This con-
clusion is strengthened by the frequency
with which effectors were detectable in
NK- LNC and TIL preparations, though
the PBL compartment had the highest
frequency of reactivity. There were no
indications of accumulation of antigen-
sensitized cells at the tumour site, in that
only 3 individuals showed draining-node
reactivity in the absence of cytotoxicity
in the blood. TIL were almost invariably
poorer effectors than those from other
sites. Factors influencing TIL activity
may be manifold, and include handling
and the presence of substances inhibitory
of lymphocyte function in the micro-
environment of the neoplasm, a recent
indication of which is the claim that
repeated washing ofTIL may restore their
lytic potential (Hutchinson et al., 1981).
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In situ there is evidence that these cells
have suppressor activity, and are less
responsive to mitogens than PBL (Vose
& Moore, 1979). With regard to the lack
of NK in LNC and TIL, unpublished
observations have shown that these popu-
lations lack the large granular lympho-
cytes which mediate natural killing
(Timonen et al., 1981).
NK cells show spontaneous cytotoxicity
against a broad range of target cells,
including autologous lymphoblastoid cell
lines (Herberman & Holden, 1978; Lei-
bold & Peter, 1978). In the present study
the activity of all populations against the
K562 cell line was monitored as a measure
of their NK effector capacity. No correla-
tion was apparent between levels of NK
and cytotoxic T cells reactive with auto-
logous targets. This was not unexpected in
view of the refractory nature of the
freshly isolated targets to NK and the
largely NK- status of LNC and TIL,
observations which in our view question
the relevance of this effector function in
control of established neoplasia.
Most PBL showed variable but sig-
nificant activity against the cell line. In
contrast with the results of others (Pross
& Baines, 1976) no decrease in lytic
potential was disclosed with advancing
disease, even in patients with widespread
metastases. Cytotoxicity was recorded in
only a minority of LNC. Whilst no rela-
tionship was found between the presence
of lymph-nodal NK and clinico-patho-
logical stage, it is of interest that nodal
NK showed different isolation characteris-
tics from those found in the blood, being
SRBC rosetting and nylon-column adher-
ent. These data are similar to those
described for NK effectors in axillary
nodes from breast cancer (Eremin et al.,
1978).
The detection of reactivity against
autologous tumour in LNC which are NK-
supports the independent nature of the
specific killer population, and offers a
means by which disease-related reactivi-
ties may be investigated, without recourse
to the tedious tumour-cell separation used
853854 B. M. VOSE, P. GALLAGHER, M. MOORE AND P. F. SCHOFIELD
here or extensive depletion ofNK effectors
from PBL samples (Bakacs et al., 1978).
Lymphocytes from 3 healthy donors and
one lung-carcinoma patient showed cyto-
toxicity for colon-carcinoma cells. The
nature of this allogeneic interaction is
unclear, though again the finding of auto-
logous reactivity in this patient in NK-
nodes suggests a target-cell susceptibility
to lysis unrelated to NK. The possibility
that such unrestrained killer activity may
result from polyclonal stimulation of
cytotoxic effector function (Bonnard et al.,
1978) similar to that when lymphocytes
are grown in conditioned media containing
T-cell growth factor (Interleukin 2) is
currently under investigation. Lympho-
cytes from blood, lymph node and tumour
can be cultured in TCGF medium and
most frequently show high cytotoxicity
for autologous and allogeneic targets,
but not K562 (Vose & Moore, 1981).
In this extensive series we have failed to
detect any correlation of specific and non-
specific lysis of colonic tumour cells with
the clinical course of the disease, in so far
as anti-tumour reactivity was present in
all clinico-pathological groups. The role
of NK and cytotoxic T cells in control or
progression of malignant disease therefore
remains obscure. The data call for clonal
expansion of the cytotoxic T-cell popula-
tion expressing preferential reactivity with
autologous tumour cells. The availability
of such cellular reagents would permit a
more exhaustive analysis of tumour speci-
ficity, and should help to determine their
biological role.
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Cancer Researclh Campaign and the Medical Research
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